Thus, correction of mutant GATA3 back to wild type impaired estrogen-dependent growth of MCF-7 breast cancer cells in vivo, and knock-in mutant GATA3 was sufficient to confer the ability of CAMA1 cells to grow as xenografts in immunocompromised mice. This evidence concerns the gene GATA3 and breast carcinoma.